Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$0.16 - $0.64 $436 - $1,746
-2,729 Reduced 2.52%
105,539 $21,000
Q1 2023

May 15, 2023

SELL
$0.44 - $0.81 $114,013 - $209,888
-259,122 Reduced 70.53%
108,268 $69,000
Q3 2022

Nov 14, 2022

BUY
$0.77 - $23.2 $8,202 - $247,149
10,653 Added 2.99%
367,390 $390,000
Q4 2021

Feb 14, 2022

BUY
$2.93 - $4.19 $218,525 - $312,498
74,582 Added 26.43%
356,737 $1.19 Million
Q2 2021

Aug 13, 2021

BUY
$3.71 - $5.18 $1.05 Million - $1.46 Million
282,155 New
282,155 $1.31 Million

Others Institutions Holding INVO

# of Institutions
1
Shares Held
14.1K
Call Options Held
0
Put Options Held
0

About INVO Bioscience, Inc.


  • Ticker INVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 12,169,700
  • Market Cap $9.86M
  • Description
  • INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.
More about INVO
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.